Though the reason for these disparate results is unclear, the severity of DM could be a possible explanation; the patients of the present study cohort were diagnosed with T2DM based on the ICD-10 (International Classification of Diseases, 10th Revision) code alone, irrespective of whether the patients received oral antidiabetes agents or insulin treatment. The gene discussed is INS; the disease is diabetes mellitus.